Most Read Articles
5 days ago
Living a sedentary lifestyle may increase the risk of cardiovascular diseases (CVD) even in people with healthy body mass index (BMI), reports a new study.
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
3 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.

Interval training improves vascular function in patients with repaired tetralogy of Fallot

11 Feb 2018
High intensity impact and resistance training consists of intense strength and cardiovascular exercises.

In adults with repaired tetralogy of Fallot (ToF), high-intensity interval training is effective in improving quality of life (QoL), vascular function, exercise capacity, fibrinogen levels and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, according to a recent study.

The researchers randomized 27 adults (mean age 38.5±8.7 years; 63 percent female) with repaired ToF to receive either high-intensity interval training (n=9), moderate-intensity continuous training (n=9) or usual care (n=9).

With a mean adherence of 91.1 percent, both exercise interventions were safe and no deaths or adverse events were recorded. There were likewise no side effects, such as dizziness or palpitations, and significant changes in cardiac size and function.

Both exercise interventions resulted in significant improvements from baseline in workload capacity (p<0.05 for both), but only interval training was significantly associated with improvements in peak oxygen uptake (21.2–22.9 mL/kg/min; p<0.05).

Similarly, only interval training led to significant improvements from baseline in vascular function parameters such as pulse wave velocity (5.4–4.7 m/s; p<0.05) and flow-mediated dilation (8.4–12.9 percent; p<0.05). Improvements were also significantly better when compared with controls (p<0.05 for both).

In terms of serum biomarkers, interval training resulted in significantly higher high-density lipoprotein cholesterol levels (1.26–1.33 mmol/L; p<0.05) but significantly reduced fibrinogen (2.67–2.46 g/L; p<0.05) and NT-proBNP (202–190 ng/L; p<0.05) levels. The continuous training regimen did not result in these changes.

In contrast, a significant improvement in scores in the mental component of the 36-item Short Form Survey was associated with the continuous exercise regimen (87–93 points; p<0.05).

“Our findings suggest differential appreciation of both exercise types–namely, that high-intensity interval training improves [peak oxygen uptake], vascular function and disease specific biomarkers, whereas continuous training improves cardiac autonomic function and mental domain of QoL,” said researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Living a sedentary lifestyle may increase the risk of cardiovascular diseases (CVD) even in people with healthy body mass index (BMI), reports a new study.
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
3 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.